The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure

Sophine B Krintel, Veit Peter Grunert, Merete L Hetland, Julia S Johansen, Matthias Rothfuss, Giuseppe Palermo, Laurent Essioux, Ursula Klause

59 Citations (Scopus)

Abstract

To investigate the frequency of anti-infliximab antibodies in patients with RA and the associations with adverse drug reactions and treatment failure.
Original languageEnglish
JournalRheumatology (Oxford, England)
Volume52
Issue number7
Pages (from-to)1245-53
Number of pages9
ISSN1462-0324
DOIs
Publication statusPublished - Jul 2013

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Radioimmunoassay
  • Registries
  • Risk Factors
  • Treatment Failure
  • Treatment Refusal
  • Young Adult

Fingerprint

Dive into the research topics of 'The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure'. Together they form a unique fingerprint.

Cite this